penicillanic acid has been researched along with Agranulocytosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Iwazawa, H; Kanenishi, K; Kosaka, S; Motoki, T; Suzuki, K; Takahashi, K; Tanaka, H; Tatsumichi, T; Yamaguchi, K | 1 |
| He, ZF; Wang, YP; Wu, XA | 1 |
| Feng, X; He, L; He, Y; Li, C; Liu, H; Liu, X; Ruan, Y; Wu, X; Zhang, Y | 1 |
| Betten, DP; Massoll, AF; Powers, SC | 1 |
| Calandra, T; Cometta, A; de Bock, R; Gaya, H; Glauser, MP; Klastersky, J; Langenaeken, J; Paesmans, M; Viscoli, C; Zinner, S | 1 |
| Iurlova, MI; Maschan, AA; Rumiantseva, TA | 1 |
2 trial(s) available for penicillanic acid and Agranulocytosis
| Article | Year |
|---|---|
Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia.
Topics: Adolescent; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infection Control; Length of Stay; Leukemia, Myeloid, Acute; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin | 2014 |
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 1995 |
4 other study(ies) available for penicillanic acid and Agranulocytosis
| Article | Year |
|---|---|
A puerperal patient with agranulocytosis during tazobactam / piperacillin administration : A case report.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2021 |
Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.
Topics: Adult; Agranulocytosis; Bone Marrow; Humans; Liver; Liver Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thrombocytopenia | 2013 |
Agranulocytosis occurrence following recent acute infectious mononucleosis.
Topics: Adolescent; Agranulocytosis; Anti-Bacterial Agents; Disease Progression; Epstein-Barr Virus Infections; Female; Fever; Humans; Infectious Mononucleosis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Failure | 2017 |
[Effectiveness of piperacillin/tazobactam in the treatment of fever of unknown etiology in patients with granulocytopenia].
Topics: Adolescent; Agranulocytosis; Child; Child, Preschool; Drug Therapy, Combination; Fever of Unknown Origin; Hematologic Diseases; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 1997 |